全文获取类型
收费全文 | 4449篇 |
免费 | 720篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 151篇 |
妇产科学 | 57篇 |
基础医学 | 756篇 |
口腔科学 | 67篇 |
临床医学 | 813篇 |
内科学 | 870篇 |
皮肤病学 | 42篇 |
神经病学 | 578篇 |
特种医学 | 116篇 |
外科学 | 495篇 |
综合类 | 105篇 |
一般理论 | 1篇 |
预防医学 | 513篇 |
眼科学 | 69篇 |
药学 | 293篇 |
中国医学 | 2篇 |
肿瘤学 | 228篇 |
出版年
2023年 | 71篇 |
2022年 | 35篇 |
2021年 | 79篇 |
2020年 | 82篇 |
2019年 | 89篇 |
2018年 | 108篇 |
2017年 | 139篇 |
2016年 | 134篇 |
2015年 | 160篇 |
2014年 | 166篇 |
2013年 | 232篇 |
2012年 | 227篇 |
2011年 | 219篇 |
2010年 | 174篇 |
2009年 | 190篇 |
2008年 | 182篇 |
2007年 | 178篇 |
2006年 | 159篇 |
2005年 | 162篇 |
2004年 | 153篇 |
2003年 | 145篇 |
2002年 | 144篇 |
2001年 | 135篇 |
2000年 | 133篇 |
1999年 | 119篇 |
1998年 | 91篇 |
1997年 | 67篇 |
1996年 | 67篇 |
1995年 | 54篇 |
1994年 | 37篇 |
1993年 | 40篇 |
1992年 | 76篇 |
1991年 | 78篇 |
1990年 | 65篇 |
1989年 | 67篇 |
1988年 | 68篇 |
1987年 | 72篇 |
1986年 | 46篇 |
1985年 | 49篇 |
1984年 | 61篇 |
1983年 | 45篇 |
1982年 | 37篇 |
1980年 | 32篇 |
1979年 | 45篇 |
1974年 | 44篇 |
1973年 | 37篇 |
1972年 | 31篇 |
1971年 | 30篇 |
1970年 | 30篇 |
1967年 | 27篇 |
排序方式: 共有5183条查询结果,搜索用时 265 毫秒
81.
PT Clayton M Doig S Ghafari C Meaney C Taylor JV Leonard M Morris AW Johnson 《Archives of disease in childhood》1998,79(2):109-115
OBJECTIVE: To establish criteria for the diagnosis of medium chain acyl-CoA dehydrogenase (MCAD) deficiency in the UK population using a method in which carnitine species eluted from blood spots are butylated and analysed by electrospray ionisation tandem mass spectrometry (ESI-MS/MS). DESIGN: Four groups were studied: (1) 35 children, aged 4 days to 16.2 years, with proven MCAD deficiency (mostly homozygous for the A985G mutation, none receiving carnitine supplements); (2) 2168 control children; (3) 482 neonates; and (4) 15 MCAD heterozygotes. RESULTS: All patients with MCAD deficiency had an octanoylcarnitine concentration ([C8-Cn]) > 0.38 microM and no accumulation of carnitine species > C10 or < C6. Among the patients with MCAD deficiency, the [C8-Cn] was significantly lower in children > 10 weeks old and in children with carnitine depletion (free carnitine < 20 microM). Neonatal blood spots from patients with MCAD deficiency had a [C8-Cn] > 1.5 microM, whereas in heterozygotes and other normal neonates the [C8-Cn] was < 1.0 microM. In contrast, the blood spot [C8-Cn] in eight of 27 patients with MCAD deficiency > 10 weeks old fell within the same range as five of 15 MCAD heterozygotes (0.38-1.0 microM). However, the free carnitine concentrations were reduced (< 20 microM) in the patients with MCAD deficiency but normal in the heterozygotes. CONCLUSIONS: Criteria for the diagnosis of MCAD deficiency using ESI-MS/MS must take account of age and carnitine depletion. If screening is undertaken at 7-10 days, the number of false positive and negative results should be negligible. Because there have been no instances of death or neurological damage following diagnosis of MCAD deficiency in our patient group, a strong case can be made for neonatal screening for MCAD deficiency in the UK. 相似文献
82.
Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom 总被引:5,自引:1,他引:4
Heath PT Booy R Azzopardi HJ Slack MP Bowen-Morris J Griffiths H Ramsay ME Deeks JJ Moxon ER 《JAMA》2000,284(18):2334-2340
CONTEXT: The schedule for Haemophilus influenzae type b (Hib) vaccination of infants in the United Kingdom consists of 3 doses given at 2, 3, and 4 months of age. Many countries include a fourth dose (booster) of Hib vaccine in the second year of life on the basis of declining Hib antibody concentrations after the primary series. Few data are available to show that this fourth dose is actually necessary. OBJECTIVE: To evaluate long-term clinical protection against Hib disease and Hib antibody concentrations following primary Hib vaccination without a booster dose. DESIGN, SETTING, AND SUBJECTS: Clinical protection study conducted between October 1992 and March 1999 in the United Kingdom, in which children developing invasive Hib disease despite vaccination in infancy with 3 doses of Hib conjugate vaccine were reported by pediatricians through an active, prospective, national survey. Separate antibody studies were conducted among 2 cohorts of children (n = 153 and n = 107) vaccinated at 2, 3, and 4 months of age with Hib conjugate vaccine and followed up to 43 and 72 months of age. MAIN OUTCOME MEASURES: Age-specific vaccine effectiveness, derived from the observed number of true vaccine failures after 3 Hib vaccine doses compared with the number of cases expected based on the age-specific rates of invasive Hib disease obtained prior to the introduction of Hib vaccines; and proportion of children in the 2 cohorts with Hib antibody concentrations of less than 0.15 and less than 1.0 microg/mL. RESULTS: Ninety-six true vaccine failures occurring after 3 vaccine doses were detected. During the study period, an estimated 4,368,200 infants in the United Kingdom received 3 doses of vaccine; therefore, the vaccine failure rate was 2.2 per 100,000 vaccinees (95% confidence interval, 1.8-2.7 per 100,000). Although vaccine effectiveness declined significantly after the first year of life (P<.001), it remained high until the sixth year of life (99.4% in children aged 5-11 months vs 97.3% in those aged 12-71 months). The proportion of cohorts 1 and 2 with anti-PRP antibody levels of less than 0.15 microg/mL increased between 12 and 72 months of age (6% at 12 months, 8% at 43 months, and 32% at 72 months; chi(2)(1) = 18.25; P<.001 for trend). CONCLUSIONS: Our results suggest that anti-PRP antibody levels and clinical protection against Hib disease wane over time after Hib vaccination at 2, 3, and 4 months of age without a booster dose at 2 years of age. The decline in clinical protection is minimal, however, suggesting that a booster dose of Hib vaccine following infant vaccination is not essential. JAMA. 2000;284:2334-2340. 相似文献
83.
Those who are asked where they would prefer to die are muchmore likely to elect to die at home. Yet it is not an easy questionto ask and, because of this, it is very easy to find an excusefor postponing the asking. A central aim of this intensely usefulbook is to 相似文献
84.
Inpatient dependency in activities of daily living predicts informal caregiver strain: A cross‐sectional study
下载免费PDF全文
![点击此处可从《Journal of clinical nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
85.
86.
87.
88.
Marshall Hagins PT PhD Andrew Rundle PH Nathan S. Consedine PhD Sat Bir S. Khalsa PhD 《Journal of clinical hypertension (Greenwich, Conn.)》2014,16(1):54-62
The purpose of this study was to compare the effects of yoga with an active control (nonaerobic exercise) in individuals with prehypertension and stage 1 hypertension. A randomized clinical trial was performed using two arms: (1) yoga and (2) active control. Primary outcomes were 24‐hour day and night ambulatory systolic and diastolic blood pressures. Within‐group and between‐group analyses were performed using paired t tests and repeated‐measures analysis of variance (time × group), respectively. Eighty‐four participants enrolled, with 68 participants completing the trial. Within‐group analyses found 24‐hour diastolic, night diastolic, and mean arterial pressure all significantly reduced in the yoga group (?3.93, ?4.7, ?4.23 mm Hg, respectively) but no significant within‐group changes in the active control group. Direct comparisons of the yoga intervention with the control group found a single blood pressure variable (diastolic night) to be significantly different (P=.038). This study has demonstrated that a yoga intervention can lower blood pressure in patients with mild hypertension. Although this study was not adequately powered to show between‐group differences, the size of the yoga‐induced blood pressure reduction appears to justify performing a definitive trial of this intervention to test whether it can provide meaningful therapeutic value for the management of hypertension. 相似文献
89.